Eva Češková

1.7k total citations
109 papers, 1.2k citations indexed

About

Eva Češková is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Eva Češková has authored 109 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Psychiatry and Mental health, 25 papers in Pharmacology and 17 papers in Cognitive Neuroscience. Recurrent topics in Eva Češková's work include Schizophrenia research and treatment (52 papers), Treatment of Major Depression (24 papers) and Functional Brain Connectivity Studies (15 papers). Eva Češková is often cited by papers focused on Schizophrenia research and treatment (52 papers), Treatment of Major Depression (24 papers) and Functional Brain Connectivity Studies (15 papers). Eva Češková collaborates with scholars based in Czechia, United States and Germany. Eva Češková's co-authors include Radovan Přikryl, Tomáš Kašpárek, Jaromír Švestka, Libor Ustohal, Hana Kučerová, Jiří Jarkovský, Michal Mikl, Daniel Schwarz, Jiří Vaníček and Radek Mareček and has published in prestigious journals such as SHILAP Revista de lepidopterología, Human Brain Mapping and The Journal of Nervous and Mental Disease.

In The Last Decade

Eva Češková

91 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Češková Czechia	21	700	335	234	197	144	109	1.2k
Raymund Schwan France	22	430 0.6×	332 1.0×	198 0.8×	68 0.3×	101 0.7×	134	1.5k
Iluminada Corripio Spain	24	923 1.3×	546 1.6×	243 1.0×	63 0.3×	52 0.4×	87	1.7k
A. Klimke Germany	22	709 1.0×	416 1.2×	227 1.0×	114 0.6×	31 0.2×	79	1.7k
Roberto Brugnoli Italy	19	459 0.7×	307 0.9×	295 1.3×	170 0.9×	33 0.2×	51	991
Kaida Jiang China	21	490 0.7×	491 1.5×	240 1.0×	74 0.4×	28 0.2×	72	1.4k
Roberto Delle Chiaie Italy	19	341 0.5×	267 0.8×	149 0.6×	233 1.2×	54 0.4×	49	916
J.-P. Olié France	16	423 0.6×	214 0.6×	186 0.8×	67 0.3×	44 0.3×	37	1.1k
K L Davis United States	14	759 1.1×	233 0.7×	62 0.3×	171 0.9×	35 0.2×	22	1.4k
M.A. Reveley United Kingdom	20	878 1.3×	431 1.3×	190 0.8×	48 0.2×	27 0.2×	37	1.5k
Rune A. Kroken Norway	24	1.0k 1.4×	560 1.7×	327 1.4×	84 0.4×	30 0.2×	95	1.8k

Countries citing papers authored by Eva Češková

Since Specialization

Citations

This map shows the geographic impact of Eva Češková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Češková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Češková more than expected).

Fields of papers citing papers by Eva Češková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Češková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Češková. The network helps show where Eva Češková may publish in the future.

Co-authorship network of co-authors of Eva Češková

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Češková. A scholar is included among the top collaborators of Eva Češková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Češková. Eva Češková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Češková, Eva, et al.. (2021). From Personalized Medicine to Precision Psychiatry?. SHILAP Revista de lepidopterología. 15 indexed citations

Češková, Eva, et al.. (2021). Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis. Neuropsychiatric Disease and Treatment. Volume 17. 1069–1075. 6 indexed citations

Ustohal, Libor, et al.. (2018). Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations. Neuropsychiatric Disease and Treatment. Volume 14. 1535–1543. 44 indexed citations

Češková, Eva. (2017). Treatment of depressive disorder with cognitive dysfunction. 18(2). 60–63.

Češková, Eva. (2016). Účinnost trazodonu v léčbě deprese a poruch spánku. 1 indexed citations

Kacířová, Ivana, et al.. (2016). Therapeutic drug monitoring in psychiatry - possibilities and use in practice. 17(1). 10–14. 2 indexed citations

Češková, Eva. (2016). Some issues of antidepressant efficacy and tolerability relevant for routine clinical practice. 17(2). 48–52. 1 indexed citations

Češková, Eva, et al.. (2012). Optimalizace farmakoterapie schizofrenní poruchy. 13(4). 156–159. 1 indexed citations

Češková, Eva. (2009). Vliv léčby antidepresivy na hmotnost. 10(4). 180–183.

10.

Češková, Eva, Radovan Přikryl, Tomáš Kašpárek, & Hana Kučerová. (2008). Aggression in first-episode schizophrenia. 2 indexed citations

11.

Kašpárek, Tomáš, Radovan Přikryl, Michal Mikl, et al.. (2007). Prefrontal but not temporal gray matter changes in males withfirst-episode schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2007(31).

12.

Češková, Eva, et al.. (2007). One-year follow-up of patients with fi rst-episode schizophrenia (comparison between remitters and non-remitters). Neuropsychiatric Disease and Treatment. 3(1). 153–160. 16 indexed citations

13.

Kašpárek, Tomáš, Radovan Přikryl, Michal Mikl, et al.. (2006). Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(1). 151–157. 38 indexed citations

14.

Češková, Eva. (2005). Deprese u kardiálních, neurologických a onkologickýchonemocnění.

15.

Přikryl, Radovan, Eva Češková, Tomáš Kašpárek, & Hana Kučerová. (2005). Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. Journal of Psychiatric Research. 40(2). 141–146. 32 indexed citations

16.

Přikryl, Radovan, et al.. (2004). Cognitive dysfunction in the first episode of schizophrenia.. The International Journal of Neuropsychopharmacology. 7(7). 124–124. 1 indexed citations

17.

Češková, Eva, et al.. (2004). The pitfalls of antidepressant treatment (gender differences). 8. 1 indexed citations

18.

Češková, Eva, et al.. (2003). Neurological soft signs in first-episode schizophrenia. European Neuropsychopharmacology. 10 indexed citations

19.

Zschiesche, M, et al.. (1996). Debrisoquine 4‐hydroxylation and sulphamethazine N‐acetylation in patients with schizophrenia and major depression. British Journal of Clinical Pharmacology. 41(5). 428–431. 3 indexed citations

20.

Češková, Eva, et al.. (1974). Clinical experience with doxepin.. PubMed. 16(3). 185–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact